Home / Business / Business News / Here's why Biogen's promising Alzheimer's drug data is also good news for Eli Lilly

Here's why Biogen's promising Alzheimer's drug data is also good news for Eli Lilly

September 29, 2022 Business, Business News

We don't own Eli Lilly exclusively for its potential Alzheimer's treatment. However, we still find Biogen's topline data to be very encouraging for Lilly.

from Business News https://ift.tt/ZUo92pB
via IFTTT https://ift.tt/hKDXMFo

No comments

Subscribe to: Post Comments ( Atom )